Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magloy Tech is a Singapore-based medtech spinout from the National University of Singapore developing bioresorbable magnesium implants for fracture fixation and related surgical applications. Its core technology uses customized magnesium-based alloys and a patented green manufacturing process to create temporary implants that dissolve after bone healing, with the goal of avoiding implant-removal surgery associated with titanium or steel hardware. The company’s lead product has been referred to publicly as OrthoMag and ResoMag, aimed at orthopedic, trauma, and craniofacial use cases. Publicly available company materials indicate completion of GLP large-animal preclinical studies and feedback from the FDA Q-Sub process supporting a 510(k) regulatory pathway. Magloy Tech appears to be an active private healthcare company focused on translating biomaterials innovation into surgical implant products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Magloy Tech.